NAPP Logo

Respiratory

Respiratory

We are a committed long-term NHS provider in respiratory medicine, supporting the delivery of real-world evidence and education. We aim to provide high-quality asthma medicines that meet genuine needs, make a positive difference to patients’ lives and offer value to the NHS.

 flutiform® k-haler® pressurised inhalation, suspension inhaler (fluticasone propionate and formoterol fumarate dihydrate) 

For further information please visit the Patient Information leaflet or visit https://www.flutiformkhaler.co.uk/uk/home/# 

SPC PIL

flutiform® inhaler (fluticasone propionate and formoterol fumarate dihydrate) 

SPC PIL

Phyllocontin® Continus® and Phyllocontin® Forte Continus® tablets (twice-daily aminophylline hydrate)

SPC PIL

Uniphyllin® Continus® tablets (twice-daily theophylline)

SPC PIL
Back to all products

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUK@napp.co.uk.

Links and resources

The following website offers information and resources for people with asthma:

Asthma UK

British Lung Foundation

Please note that these websites are owned and managed by patient organisations/charities. Napp is not responsible for any of the content within these websites.

Date of preparation: February 2019 UK/CORP-18046a

Stay connected

You are now leaving napp.co.uk. Napp does not accept any responsibility for the third party site.

Please click "Continue to external link" if you want to proceed.

Back to s://napp.co.uk
Continue to external link